About the International Journal of Personalized Medicine
Advancing biomarker discovery, validation, and molecular stratification to enable precision-guided therapeutic strategies through rigorous peer-reviewed research.
Pioneering Biomarker Science for Personalized Medicine
The International Journal of Personalized Medicine (IJPM) serves as a premier platform for biomarker discovery and validation research that underpins personalized therapeutic approaches. We publish high-impact studies exploring molecular signatures, stratification algorithms, and patient-specific factors that influence treatment response—without crossing into clinical decision-making territory.
Our mission centers on advancing the scientific foundations that enable personalized medicine: identifying biomarkers, validating predictive models, and developing stratification tools that researchers and clinicians can eventually translate into practice. IJPM bridges laboratory discovery with translational potential, fostering collaboration among molecular biologists, genomics researchers, bioinformaticians, and pharmaceutical scientists.
As an open access journal backed by Open Access Pub, IJPM ensures that biomarker research reaches global audiences without subscription barriers, accelerating the pace of discovery and validation in personalized medicine science.
IJPM publishes original research, methodological advances, and comprehensive reviews focused exclusively on the scientific foundations of personalized medicine. Our scope emphasizes biomarker identification, validation methodologies, molecular profiling, and algorithmic development—the essential building blocks that enable patient stratification.
Accepted Manuscript Types
IJPM provides a streamlined, author-friendly publishing experience designed to accelerate dissemination of biomarker research while maintaining rigorous quality standards.
- Rapid Peer Review: Efficient editorial handling with constructive feedback from experts in biomarker science, genomics, and molecular profiling.
- Open Access Impact: Immediate worldwide availability under Creative Commons Attribution License, maximizing research visibility and citation potential.
- Author Copyright Retention: Authors retain full copyright, enabling unrestricted use of their work for presentations, teaching, and future publications.
- Fast Publication: Streamlined production process ensures rapid online publication of accepted manuscripts.
- Global Visibility: Wide indexing across academic databases and search platforms, increasing discoverability by researchers worldwide.
- No Submission Fees: Authors pay only upon acceptance, with transparent Article Processing Charges and waiver options for qualifying researchers.
- Professional Copyediting: Expert editorial support to enhance clarity and presentation without altering scientific content.
- Data Sharing Support: Guidance and infrastructure for open data deposition, enhancing reproducibility and scientific impact.
IJPM maintains a transparent, efficient editorial workflow designed to provide timely decisions while ensuring thorough peer evaluation.
Submission
Submit manuscripts through the online portal or via email to [email protected]. Ensure adherence to author guidelines including structured abstracts and appropriate reporting standards.
Editorial Assessment
Managing editors conduct initial screening for scope fit, ethical compliance, and technical quality. Manuscripts aligned with IJPM's biomarker science focus proceed to peer review.
Peer Review
Expert reviewers evaluate scientific merit, methodological rigor, data quality, and contribution to personalized medicine research. Authors receive constructive feedback to strengthen manuscripts.
Editorial Decision
Editors render decisions based on reviewer recommendations and alignment with journal standards. Authors receive clear guidance for revisions when applicable.
Publication
Accepted manuscripts undergo professional copyediting and formatting before rapid online publication with full open access.
IJPM's editorial board comprises distinguished researchers specializing in genomics, molecular biology, pharmacogenomics, bioinformatics, and biomarker development. This diverse expertise ensures balanced evaluation across biomarker discovery methodologies, validation approaches, and emerging technologies in personalized medicine research.
Board members provide strategic guidance on journal scope, review special issues, and mentor early-career researchers contributing to biomarker science. Their commitment to scientific rigor and methodological excellence maintains IJPM's reputation as a trusted venue for high-quality personalized medicine research.
IJPM operates under an open access model supported by Article Processing Charges (APCs) that cover peer review, editing, production, and perpetual online hosting. Charges apply only to accepted manuscripts, ensuring authors invest only in successfully peer-reviewed work.
Advance Biomarker Science with IJPM
Join the global community of researchers advancing personalized medicine through rigorous biomarker discovery and validation. Submit your research to a journal that prioritizes scientific excellence, rapid publication, and worldwide accessibility.
